Increased resistance of encapsulated Bacteroides fragilis to clindamycin.

Abstract:

:The antimicrobial susceptibility and in vitro growth curve of 4 nonencapsulated and 4 encapsulated isolates of Bacteroides fragilis were determined for clindamycin. The MIC of the nonencapsulated isolates was 1-2 dilutions less (0.062-0.25 microgram/ml) than the MIC for their encapsulated counterparts (0.25-0.5 microgram/ml). No difference was noted in the bacterial growth of the nonencapsulated or encapsulated isolates when incubated without clindamycin. The decline in the number of nonencapsulated isolates was significantly lower (p < 0.05) as compared to the encapsulated isolates when incubated with 0.1 or 0.4 microgram/ml of clindamycin. These results illustrate the higher susceptibility of nonencapsulated B. fragilis isolates to clindamycin as compared to their encapsulated counterparts. Since B. fragilis becomes more encapsulated during the infectious process, this finding underscores the advantage of early antimicrobial prophylaxis and therapy.

journal_name

Chemotherapy

journal_title

Chemotherapy

authors

Brook I,Gillmore JD

doi

10.1159/000239164

subject

Has Abstract

pub_date

1994-01-01 00:00:00

pages

16-20

issue

1

eissn

0009-3157

issn

1421-9794

journal_volume

40

pub_type

杂志文章
  • Effect of L- and D-lysine on the growth of Ehrlich ascites tumour.

    abstract::Contrary to L-lysine, D-lysine showed no inhibitory effect on growth of Ehrlich ascites tumour cell in in vivo studies. The in vitro studies on the growth of cultured Ehrlich ascites tumour cells showed similar results, namely, the growth of tumour cells was inhibited when cultured in 0.02 or 0.03 M L-lysine; while 0....

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238657

    authors: Choy YM,Fung KP

    更新日期:1989-01-01 00:00:00

  • Acute infantile pneumonopathies treated with fosfomycin.

    abstract::Reference is made to the results obtained in 24 children, from 11 months to 12 years, affected with acute pneumopathies and treated with fosfomycin with a dosage of 200 mg/kg/day. In all cases a clinical, radiological, biological and bacteriological study was carried out. At the same time, levels of fosfomycin in plas...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000222069

    authors: Llorens J,Ley G,Forés A,Olay T

    更新日期:1977-01-01 00:00:00

  • Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. III. beta-Lactam antibiotics and fosfomycin.

    abstract::Neither cefoperazone, cefotaxime, mezlocillin nor piperacillin significantly killed intraphagocytic bacteria of representative assay strains of Serratia marcescens, as determined with 55 vol% of fresh defibrinated human blood treated with 2 mg/ml of phenylbutazone, which permitted phagocytic ingestion of bacteria, but...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238173

    authors: Traub WH

    更新日期:1983-01-01 00:00:00

  • Pharmacokinetics of Benzylpenicillin (Penicillin G) during Prolonged Intermittent Renal Replacement Therapy.

    abstract::Prolonged intermittent renal replacement therapy (PIRRT) is an increasingly adopted method of renal replacement in critically ill patients. Like continuous renal replacement therapy, PIRRT can alter the pharmacokinetics (PK) of many drugs. In this setting, dosing data for antibiotics like benzylpenicillin are lacking....

    journal_title:Chemotherapy

    pub_type:

    doi:10.1159/000499375

    authors: Cheng V,Rawlins M,Chang T,Fox E,Dyer J,Allen C,Litton E,Page MM,Hoad K,Roberts JA

    更新日期:2019-01-01 00:00:00

  • Phase II trial of neoadjuvant cisplatin, 5-fluorouracil and interferon-alpha in operable squamous cell carcinoma of the esophagus.

    abstract:BACKGROUND:The combination of 5-fluorouracil (5-FU), cisplatin and interferon (IFN)-alpha was found to result in a high response rate in advanced esophageal squamous cell carcinoma (SCC). METHODS:Resectable cases of esophageal SCC were treated with 3 cycles of chemotherapy consisting of cisplatin 70 mg/m(2) i.v. on da...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000151353

    authors: Bazarbashi S,Abdelsalam M,Amin T,El-Bassiouni M,Soudy H,Elweshi A,Alhusseiny H,Rehman K,Memon M,Ajarim D

    更新日期:2008-01-01 00:00:00

  • Rifaximin in the treatment of infectious diarrhea.

    abstract::Rifaximin matches the criteria for an ideal agent for the treatment of infectious diarrhea. It has excellent activity against a broad range of enteropathogens. It is nonabsorbable, which may help explain its excellent side effect profile and lack of emergence of resistance because of high stool levels that are not lik...

    journal_title:Chemotherapy

    pub_type: 杂志文章,评审

    doi:10.1159/000081992

    authors: Ericsson CD,DuPont HL

    更新日期:2005-01-01 00:00:00

  • Population pharmacokinetics and penetration into prostatic, seminal, and vaginal fluid for ciprofloxacin, levofloxacin, and their combination.

    abstract:BACKGROUND:Our objectives were to assess the pharmacokinetic interaction and body fluid penetration of ciprofloxacin and levofloxacin. METHODS:This study was a single-dose open randomized three-way crossover in 15 healthy volunteers receiving 500 mg oral levofloxacin, 500 mg oral ciprofloxacin, or 250 mg levofloxacin ...

    journal_title:Chemotherapy

    pub_type: 杂志文章,随机对照试验

    doi:10.1159/000329520

    authors: Bulitta JB,Kinzig M,Naber CK,Wagenlehner FM,Sauber C,Landersdorfer CB,Sörgel F,Naber KG

    更新日期:2011-01-01 00:00:00

  • Bacteriological epidemiology and treatment of bacterial vaginosis.

    abstract::One hundred symptomatic women with clinical bacterial vaginosis (BV) were enrolled in this study. The bacteriological epidemiology of BV and efficacy of oral or vaginal administration of antimicrobial agents for treatment of BV were investigated. The epidemiology of BV was investigated before antimicrobial therapy. Fi...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239425

    authors: Mikamo H,Kawazoe K,Izumi K,Ito K,Katoh N,Watanabe K,Ueno K,Tamaya T

    更新日期:1996-01-01 00:00:00

  • In vitro evaluation of new penicillins and cephalosporins upon P. aeruginosa and their interaction with mecillinam.

    abstract::The in vitro activity of the new semisynthetic ureidopenicillins azlocillin (AZ) and mezlocillin (MZ), and of the new cephalosporin cefsulodin (CEF) were determined against 50 carbenicillin-sensitive (CARs) and 50 carbenicillin-resistant (CARr) P. aeruginosa clinical isolates. In the CARs group the most active antibio...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000237918

    authors: Perea EJ,Palomares JC,García-Iglesias MC

    更新日期:1980-01-01 00:00:00

  • In vitro synergy studies using aztreonam and fluoroquinolone combinations against six species of Gram-negative bacilli.

    abstract:BACKGROUND:Combination antimicrobial therapy is often necessary to eradicate infections caused by gram-negative bacteria. METHODS:To evaluate the potential benefit of aztreonam and fluoroquinolone combination therapy, the activity of aztreonam in combination with ciprofloxacin, gatifloxacin, levofloxacin and moxifloxa...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000069786

    authors: Critchley IA,Sahm DF,Kelly LJ,Karlowsky JA

    更新日期:2003-05-01 00:00:00

  • Biliary excretion of cefaclor. Experimental and clinical study.

    abstract::Biliary excretion of cefaclor, a new orally active cephalosporin, was studied in vitro using an isolated rabbit liver preparation perfused for 3 h (n = 5). Under these conditions, bile recovery amounted to 2.3% of the cefaclor dose added to the circulating blood (10 mg). In humans, after oral administration of a 1-gra...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238075

    authors: Brogard JM,Pinget M,Comte F,Adloff M,Lavillaureix J

    更新日期:1982-01-01 00:00:00

  • Lipid peroxides in the polychemotherapy of cancer patients.

    abstract::There is evidence that a variety of anticancer drugs exert their cytotoxic activity by a free-radical-mediated mechanism. These drugs include anthracyclines such as adriamycin, daunorubicin, 4-epi-adriblastin as well as bleomycin, procarbazine, vincristin, cyclophosphamide, etoposide and mitomycin C. The aim of this s...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239163

    authors: Look MP,Musch E

    更新日期:1994-01-01 00:00:00

  • Association between antibiotic resistance and the expression of Dr adhesin among uropathogenic Escherichia coli.

    abstract:BACKGROUND:Urinary tract infections (UTIs) are a significant health problem and Escherichia coli has been exported to be the primary pathogen in approximately 80% of cases. E. coli express structures called adhesins, fimbriae or pili that help them bind to specific tissue receptors. One such adhesin is Dr, which binds ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000048507

    authors: Kachroo BB

    更新日期:2001-03-01 00:00:00

  • Influence of subinhibitory concentrations of protein-synthesis-inhibiting antibiotics on production and release of the pneumococcal virulence factor pneumolysin in vitro.

    abstract:OBJECTIVE:Pneumolysin is an important virulence factor of Streptococcus pneumoniae with cytotoxic and proinflammatory activities released during growth and autolysis. At concentrations above the minimal inhibitory concentration, the protein-synthesis-inhibiting antibiotics erythromycin, clindamycin and rifampicin inhib...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000107691

    authors: Spreer A,von Ruden C,Mitchell TJ,Eiffert H,Nau R

    更新日期:2007-01-01 00:00:00

  • Cefotaxime (HR-756) in urinary tract infections.

    abstract::A total of 30 hospitalized patients with upper and lower urinary tract infections were treated with cefotaxime (HR-756) by intramuscular or intravenous route. All patients had a monomicrobial infection, and the major part of bacterial isolates were gram-negative bacilli (83%) while gram-positive cocci accounted only f...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238061

    authors: Paradisi F,Cristiano P,Mirone V,D'Armiento V,Iovene MR

    更新日期:1982-01-01 00:00:00

  • In vitro susceptibility of Salmonella to ciprofloxacin and pefloxacin compared with three other antibiotics.

    abstract::The in vitro susceptibilities of 703 clinical isolates of Salmonella to ciprofloxacin (CIP) and pefloxacin (PEF) were compared with those to trimethoprim-sulfamethoxazole (TMP-SMZ), chloramphenicol (CO) and ampicillin (AP). All isolates were susceptible to CIP, while PEF inhibited 90.7% of the strains. In contrast, re...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238745

    authors: Campos LC,dos Reis EM,Ribeiro Dias JC

    更新日期:1990-01-01 00:00:00

  • Inhibition of glycolysis and respiration of sarcoma-180 cells by echitamine chloride.

    abstract::Malignant tumors are known to exhibit high rates of glycolytic activity leading to high production of lactic acid. Hence, neoplastic cells have elevated activity of enzymes responsible for glycolysis. Echitamine chloride, an indole alkaloid extracted from the bark of Alstonia scholaris, has been reported to have a hig...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000007115

    authors: Saraswathi V,Ramamoorthy N,Subramaniam S,Mathuram V,Gunasekaran P,Govindasamy S

    更新日期:1998-05-01 00:00:00

  • Tissue distribution of cefotetan in patients with Crohn's disease.

    abstract::Concentrations of cefotetan in the intestinal wall of patients with Crohn's disease were investigated with the method of tissue homogenates with the aim to evaluate the effects of inflammation on tissue distribution. Twenty-four patients who underwent surgery were treated with a 2-gram single dose of cefotetan intrave...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238871

    authors: Mazzei T,Tonelli F,Anastasi A,Ficari F,Novelli A,Periti P

    更新日期:1991-01-01 00:00:00

  • Feasibility study of adjuvant chemotherapy of S-1 and carboplatin for completely resected non-small cell lung cancer.

    abstract:BACKGROUND:The purpose of this study was to evaluate the feasibility and compliance of adjuvant chemotherapy of S-1 plus carboplatin for patients with completely resected non-small cell lung cancer (NSCLC) of pathological stage IB-IIIB. METHODS:S-1 was given orally at a dose of 80 mg/m²/day for 2 weeks, followed by a ...

    journal_title:Chemotherapy

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1159/000351101

    authors: Komazaki Y,Sakashita H,Furuiye M,Fujie T,Tamaoka M,Sumi Y,Miyazaki Y,Kojima K,Jin Y,Inase N

    更新日期:2013-01-01 00:00:00

  • Antiviral activity of a pyrazino-pyrazine derivative.

    abstract::The 2,3-dihydroxy-6-bromo-pyrazino-[2,3-beta]-pyrazine is a substance selected during the antiviral screening of pyrazino-pyrazine derivatives. The compound shows antiviral activity in vitro against measles, NDV, some influenza viruses and against herpes simplex and zoster, infectious canine hepatitis and vaccinia vir...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000221862

    authors: Verini MA,Fioretti A,Casazza AM,Sanfilippo A,Palamidessi G,Ghione M

    更新日期:1975-01-01 00:00:00

  • Gemcitabine and Vinorelbine Combination Chemotherapy in Taxane-Pretreated Patients with Metastatic Breast Cancer: A Phase II Study of the Kinki Multidisciplinary Breast Oncology Group (KMBOG) 1015.

    abstract:BACKGROUND:This phase II study was conducted to evaluate the efficacy and safety of the chemotherapy combination of gemcitabine and vinorelbine in taxane-pretreated Japanese metastatic breast cancer patients. METHODS:In this multicenter, phase II, single-arm study, patients with recurrent or metastatic HER2-negative b...

    journal_title:Chemotherapy

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1159/000475879

    authors: Yamamura J,Masuda N,Yamamoto D,Tsuyuki S,Yamaguchi M,Tanaka S,Tsurutani J,Tokunaga S,Yoshidome K,Mizutani M,Aono T,Ooe A,Tanino H,Matsunami N,Yasojima H,Nakayama T,Nishida Y

    更新日期:2017-01-01 00:00:00

  • Dimers of nostocarboline with potent antibacterial activity.

    abstract:OBJECTIVES:In this study, the in vitro antimicrobial activity and spectrum of new dimeric compounds derived from the cyanobacterial alkaloid nostocarboline were investigated. The mechanism of action and selectivity to bacteria were studied and compared to the cationic antiseptic chlorhexidine. METHODS:Minimal inhibito...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000320033

    authors: Locher HH,Ritz D,Pfaff P,Gaertner M,Knezevic A,Sabato D,Schroeder S,Barbaras D,Gademann K

    更新日期:2010-01-01 00:00:00

  • The effect of tinidazole on several ciliates.

    abstract::The effect of tinidazole on several ciliates (Stylonychia muscorum, Stylonychia mytilus, Tetrahymena pyriformis, Vorticella companula) has been studied. There is a very pronounced difference in sensitivity against this drug between the free-living ciliates here investigated and certain parasitic protozoa. A high resis...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000237820

    authors: Alonso P

    更新日期:1979-01-01 00:00:00

  • Regulation of apoptosis reduction in the cisplatin-resistant A431 cell line by Bcl-2 and CPP32.

    abstract::Cisplatin (cis-diamminedichloroplatinum(II), CDDP) is one of the most important chemotherapeutic agents; however, the mechanisms of resistance to this drug are still unknown. Recent reports have demonstrated that chemotherapy can induce apoptosis in some cancer cells, indicating that apoptosis may play a very importan...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000007258

    authors: Mese H,Sasaki A,Alcalde RE,Nakayama S,Matsumura T

    更新日期:2000-01-01 00:00:00

  • No Therapeutic Effect of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Retreatment Despite T790M Disappearance: Case Report of 3 Cases.

    abstract:BACKGROUND:T790M is a major cause of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) resistance, but the clinical significance of T790M disappearance is unknown. CASE REPORT:We report 3 cases of pulmonary adenocarcinoma which did not respond to EGFR-TKI retreatment even with T790M disappearance...

    journal_title:Chemotherapy

    pub_type:

    doi:10.1159/000491937

    authors: Kodama T,Watanabe K,Shinkai M,Kaneko T

    更新日期:2018-01-01 00:00:00

  • A new model examining intracellular and extracellular activity of amoxicillin, azithromycin, and clarithromycin in infected cells.

    abstract::An in vitro infection model was created using a suspension of macrophages, polymorphonuclear leukocytes, lymphocytes, fibroblasts, and human serum to which pathogen and antibiotic were added. Separate intracellular and extracellular antibiotic concentrations and activity against Staphylococcus aureus and Legionella pn...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238987

    authors: Scaglione F,Demartini G,Dugnani S,Fraschini F

    更新日期:1993-11-01 00:00:00

  • Surveillance of antimicrobial susceptibility among bacterial isolates from intensive care unit patients of a tertiary-care university hospital in Iran: 2006-2009.

    abstract:BACKGROUND:This study was conducted to determine the antimicrobial susceptibility patterns among common pathogens in the intensive care unit (ICU) of a university hospital in Iran between 2006 and 2009. METHODS:The isolates cultured in appropriate media and antimicrobial susceptibility were determined by disk diffusio...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000321032

    authors: Mohammadtaheri Z,Pourpaki M,Mohammadi F,Namdar R,Masjedi MR

    更新日期:2010-01-01 00:00:00

  • Modulating effect of subinhibitory concentrations of compound LY 127935 on the virulence of Escherichia coli in the mouse.

    abstract::The filamentous forms of a serum resistant Escherichia coli strain developed under in vitro exposure to subminimal inhibitory concentration of the compound LY 127935 showed a higher resistance against host defence than the nontreated control bacteria. Significantly diminished LD50 values and a longer lasting persisten...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238068

    authors: Pusztai-Markos Z,Pranada F,Leimbrock C

    更新日期:1982-01-01 00:00:00

  • In vitro and in vivo studies of the action of rifampicin, clofazimine and B1912 on Mycobacterium marinum.

    abstract::Rifampicin (RMP) and two riminophenazine compounds (B663 and B1912) suppressed the growth of Mycobacterium marinum in vitro and in a mouse footpad infection. At appropriate concentrations and dietary dosage, all three drugs showed bactericidal activity in vitro and in vivo. On the basis of minimum inhibitory concentra...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000221931

    authors: Banerjee DK,Holmes IB

    更新日期:1976-01-01 00:00:00

  • Lack of effect of gemifloxacin on the steady-state pharmacodynamics of warfarin in healthy volunteers.

    abstract::Gemifloxacin is a novel fluoroquinolone with a broad spectrum of activity. This double-blind, randomized, parallel-group study was designed to demonstrate the lack of effect of steady-state concentrations of gemifloxacin on the pharmacodynamic effects of warfarin. Healthy male subjects received loading doses of warfar...

    journal_title:Chemotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1159/000007243

    authors: Davy M,Bird N,Rost KL,Fuder H

    更新日期:1999-11-01 00:00:00